Advertisement

Diabetic Nephropathy: Pathophysiology, Clinical Course and Susceptibility

  • GianCarlo Viberti
  • James D. Walker
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 259)

Abstract

The clinical diagnosis of diabetic nephropathy in an insulin-dependent patient relies on the detection of persistent proteinuria (i.e., urinary total protein excretion rate greater than 0.5 g/24h) after 10 years or more of the disease, with concomitant diabetic retinopathy and rising arterial pressure, but without signs of other renal disease, urinary tract infection or heart failure. Diabetic glomerulosclerosis is found at renal biopsy in over 90% of the cases, confirming the diagnosis (1,2). Epidemiological studies show that, cumulatively, nephropathy develops in approximately 35% of insulin-dependent patients, and it is mostly in this kind of patient that the natural history of this disorder has been outlined (1,3). Noninsulin-dependent diabetics of European origin seem to develop nephropathy less frequently than insulin-dependent patients, but because of their larger number, the actual number of patients developing end-stage renal failure is approximately the same (4).

Keywords

Glomerular Filtration Rate Diabetic Nephropathy Albumin Excretion Rate Diabetic Kidney Disease Urinary Albumin Excretion Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    A.R. Andersen, J. S. Christiansen, J.K. Andersen, S. Kreiner, T. Deckert, Diabetic nephropathy in Type I (insulin-dependent) diabetes: an epidemiological study, Diabetologia 25:496–501 (1983).PubMedCrossRefGoogle Scholar
  2. 2.
    A.C. Thomsen, The kidney in diabetes mellitus, Thesis, Copenhagen, Munksgaard (1965).Google Scholar
  3. 3.
    A.S. Krolewski, J.H. Warram, A.R. Christlieb, E.J. Busick, C.R. Kahn, The changing natural history of nephropathy in Type I diabetes, Am. J. Med. 78:785–794 (1985).PubMedCrossRefGoogle Scholar
  4. 4.
    B. Rettig and S.M. Teusch, The incidence of end-stage renal failure in Type I and Type II diabetes mellitus, Diab. Nephropathy 3:26–27 (1984).Google Scholar
  5. 5.
    G.C. Viberti, R.W. Bilous, D. Mackintosh, H. Keen, Monitoring glomerular function in diabetic nephropathy. A prospective study, Am. J. Med. 74:256–264 (1983).PubMedCrossRefGoogle Scholar
  6. 6.
    H.H. Parving, A.R. Andersen, U.M. Smidt, E. Hommel, E.R. Mathiesen, P.A. Svendsen, Effect of antihypertensive treatment on kidney function in diabetic nephropathy, Brit. Med. J. 294:1443–1447 (1987).CrossRefGoogle Scholar
  7. 7.
    E.R. Mathiesen, B. Oxenboll, K. Johansen, P. Aa Svendsen, T. Deckert, Incipient nephropathy in Type I (insulin-dependent) diabetes, Diabetologia 26:406–410 (1984).PubMedCrossRefGoogle Scholar
  8. 8.
    M.J. Wiseman, G.C. Viberti, D. Mackintosh, R.J. Jarrett, H. Keen, Glycemia, arterial pressure and microalbuminuria in Type I (insulin-dependent) diabetes mellitus, Diabetologia 26:401–405 (1984).PubMedCrossRefGoogle Scholar
  9. 9.
    G.C. Viberti and H. Keen, The patterns of proteinuria in diabetes mellitus, Diabetes 33:686–692 (1984).PubMedGoogle Scholar
  10. 10.
    G.C. Viberti, R.W. Bilous, D. Mackintosh, J.J. Bending, H. Keen, Longterm correction of hyperglycemia and progression of renal failure in insulin-dependent diabetes, Br. Med. J. 286:598–602 (1983).CrossRefGoogle Scholar
  11. 11.
    J.J. Bending, G.C. Viberti, P.J. Watkins, H. Keen, Intermittent clinical proteinuria and renal function in diabetes: evolution and effect of glycemic control, Br. Med. J. 292:83–86 (1986).CrossRefGoogle Scholar
  12. 12.
    S. Bjorck, G. Nyberg, H. Mulec, G. Granerus, H. Herlitz, M. Aurell, Beneficial effects of angiotensin-converting enzyme inhibition on renal function in patients with diabetic nephropathy, Br. Med. J. 293:471–474 (1986).CrossRefGoogle Scholar
  13. 13.
    E. Hommel, H.H. Parving, E. Mathiensen, B. Edsberg, M.D. Nielsen, J. Giese, Effect of Captopril on kidney function in insulin-dependent diabetic patients with nephropathy, Br. Med. J. 293:467–470 (1986).CrossRefGoogle Scholar
  14. 14.
    A.C. Taguma, Y. Kitamoto, G. Futaki, H. Ueda, H. Monma, M. Ishizakli, H. Takalashli, H. Sekino, Y. Sasaki, Effects of Captopril on heavy proteinuria in azotemic diabetics, N. Engl. J. Med. 313:1617–1620 (1985).PubMedCrossRefGoogle Scholar
  15. 15.
    R. Zatz, T. Dunn, S. Meyer, S. Anderson, H.G. Rennke, B.M. Brenner, Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension, J. Clin. Invest. 77: 1925–1930 (1986).PubMedCrossRefGoogle Scholar
  16. 16.
    J. Bergstrom, Discovery and rediscovery of low-protein diet, Clin. Nephrol. 21(1):29–35 (1984).PubMedGoogle Scholar
  17. 17.
    J.B. Rosman, S. Meijer, W.J. Sluilter, P.M.T. Wee, T. Piers-Becht, A.J.M. Dunker, Prospective randomized trial of early dietary protein restriction in chronic renal failure, Lancet II:1291–1295 (1984).CrossRefGoogle Scholar
  18. 18.
    P-O. Attman, H. Bucht, O. Larsson, G. Uddebom, Protein-reduced diet in diabetic renal failure, Clin. Nephrology 19:217–220 (1983).Google Scholar
  19. 19.
    J.J. Bending, R. Dodds, J.D. Walker, H. Keen, G.C. Viberti, Dietary protein restriction delays the progression of diabetic renal failure, Diabetologia 30:598A (1987).Google Scholar
  20. 20.
    K. Borch-Johnsen, P.K. Andersen, T. Deckert, The effect of proteinuria on the relative mortality in Type I (insulin-dependent) diabetes mellitus, Diabetologia 28:590–596 (1985).PubMedCrossRefGoogle Scholar
  21. 21.
    K. Borch-Johnsen and S. Kreiner, Proteinuria: value as predictor of cardiovascular mortality in insulin-dependent diabetes mellitus, Br. Med. J. 294:1651–1654 (1987).CrossRefGoogle Scholar
  22. 22.
    C.E. Mogensen, Renal function changes in diabetes, Diabetes 25:872–879 (1976).PubMedGoogle Scholar
  23. 23.
    H. Keen and C. Chlouverakis, An immunoassay for urinary albumin at low concentration, Lancet II:913–916 (1963).CrossRefGoogle Scholar
  24. 24.
    G.C. Viberti, J.C. Pickup, R.J. Jarrett, H. Keen, Effect of control of blood glucose on urinary excretion of albumin and B2 microglobulin in insulin-dependent diabetics, N. Engl. J. Med. 300:638–642 (1979).PubMedCrossRefGoogle Scholar
  25. 25.
    C.E. Mogensen and C.K. Christensen, Predicting diabetic nephropathy insulin-dependent patients, N. Engl. J. Med. 311:89–93 (1984).PubMedCrossRefGoogle Scholar
  26. 26.
    H.H. Parving, E. Hommel, E. Mathiesen, P. Skott, B. Edsberg, M. Bahnsen, M. Lauritzen, P. Hougaard, E. Lauritzen, Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin-dependent diabetes, Br. Med. J. 296:156–160 (1988).CrossRefGoogle Scholar
  27. 27.
    G.C. Viberti, M.J. Wiseman, S. Redmond, Microalbuminuria: Its history and potential for prevention of clinical nephropathy in diabetes mellitus, Diab. Nephropath. 3:70–82 (1984).Google Scholar
  28. 28.
    B. Feldt Rasmussen and E. Mathiesen, Variability of urinary albumin excretion in incipient diabetic nephropathy, Diab. Nephropath. 3:101–103 (1984).Google Scholar
  29. 29.
    D.J.F. Rowe, H. Bagga, P.B. Betts, Normal variations in the rate of albumin excretion and albumin to creatinine ratios in overnight and daytime urine collections in nondiabetic children, Br. Med. J. 291:693–694 (1985).CrossRefGoogle Scholar
  30. 30.
    D.L. Cohen, C.L. Close, G.C. Viberti, The variability of overnight urinary albumin excretion in insulin-dependent and normal subjects, Diab. Med. 4:437–440 (1987).CrossRefGoogle Scholar
  31. 31.
    G.C. Viberti, R.D. Hill, R.J. Jarrett, U. Mahamud, H. Keen, Microalbuminuria as predictor of clinical nephropathy in insulin-dependent diabetes mellitus, Lancet I:1430–1432 (1982).CrossRefGoogle Scholar
  32. 32.
    B. Feldt-Rasmussen, E.R. Mathiesen, T. Deckert, Effect of two years of strict metabolic control of progression of incipient nephropathy in insulin-dependent diabetes, Lancet II:1300–1304 (1986).CrossRefGoogle Scholar
  33. 33.
    C.F. Close, On behalf of the Microalbuminuria Collaborative Study. The prevalence of at-risk microalbuminurics in a population of nonproteinuric, insulin-dependent diabetic subjects, Diabetic Med.:328A (1986).Google Scholar
  34. 34.
    P. Cambier, Application de la theorie de Rehberg a l’etude clinique des affections renales et du diabete, Annales de Medicine 35:273–299 (1934).Google Scholar
  35. 35.
    E. Fiaschi, B. Grassi, G. Andres, La funzione renale nel diabete mellito, Rassegna di fisiopatologia clinica e terapeutica 4:373–410 (1952).Google Scholar
  36. 36.
    J. Ditzel and M. Schwartz, Abnormal glomerular filtration rate in shortterm insulin-treated diabetic subjects, Diabetes 16:264–267 (1967).PubMedGoogle Scholar
  37. 37.
    C.E. Mogensen, Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus, Scan. J. Clin. Lab. Invest. 28:91–100 (1971).CrossRefGoogle Scholar
  38. 38.
    J.S. Christiansen, J. Gammelgaard, M. Frandsen, H.H. Parving, Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics, Diabetologia 20:451–456 (1981).PubMedGoogle Scholar
  39. 39.
    M.J. Wiseman, G.C. Viberti, H. Keen, Threshold effect of plasma glucose in the glomerular hyperfiltration of diabetes, Nephron 38:257–260 (1984).PubMedCrossRefGoogle Scholar
  40. 40.
    G. Stalder and R. Schmid, Severe functional disorders of glomerular capillaries and renal hemodynamics in treated diabetes mellitus during childhood, Ann. Paediatri. 193:129–138 (1959).Google Scholar
  41. 41.
    T.H. Hostetter, J.C. Troy, B.M. Brenner, Glomerular hemodynamics in experimental diabetes mellitus, Kidney Int. 19:410–415 (1981).PubMedCrossRefGoogle Scholar
  42. 42.
    P.K. Jensen, J.S. Christiansen, K. Steven, H.H. Paving, Renal function in streptozotocin-diabetic rats, Diabetologia 21:409–414 (1981).PubMedCrossRefGoogle Scholar
  43. 43.
    E. Hommel, E. Mathiesen, S. Arnold-Larsen, B. Edsberg, U.B. Olsen, H.H. Parving, Effects of indomethacin on kidney function in Type I (insulin-dependent) diabetic patients with nephropathy, Diabetologia 30:78–81 (1987).PubMedGoogle Scholar
  44. 44.
    M. Schambelan, S. Blake, J. Sraer, M. Bens, M.P. Nivez, F. Wahbe, Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus, J. Clin. Invest. 75:404–412 (1985).PubMedCrossRefGoogle Scholar
  45. 45.
    R. Barnett, L. Scharschmidt, K.O. Young-Hyeh, D. Schlondorff, Comparison of glomerular and mesangial prostaglandin synthesis and glomerular contraction in two rat models of diabetes mellitus, Diabetes 36:1468–1475 (1987).PubMedCrossRefGoogle Scholar
  46. 46.
    D.M. Brown, M.W. Steffes, P. Thibert, S. Azar, S.H. Mauer, Glomerular manifestation of diabetes in the BB rat, Metabolism 32:5131–5135 (1983).Google Scholar
  47. 47.
    A.F. Nakhooda, A.A. Like, C.I. Chappel, F.T. Murray, B.B. Marliss, The spontaneously diabetic Wistar rat: metabolic and morphologic studies, Diabetes 26:100–112 (1977).PubMedCrossRefGoogle Scholar
  48. 48.
    A.J. Cohen, D.M. McCarthy, R.R. Rossetti, Renin secretion by the spontaneously diabetic rat, Diabetes 35:341–346 (1986).PubMedCrossRefGoogle Scholar
  49. 49.
    J.I. Kreisberg and P.Y. Patel, The effects of insulin, glucose and diabetes on prostaglandin production by rat kidney glomeruli and cultured glomerular mesangial cells, Prostaglandins Leukotrienes Med. 11:431–442 (1983).CrossRefGoogle Scholar
  50. 50.
    P.K. Jensen, K. Steven, H. Blaehr, J.S. Christiansen, H.H. Parving, Effects of indomethacin on glomerular hemodynamics in experimental diabetes, Kidney Int. 29:490–495 (1986).PubMedCrossRefGoogle Scholar
  51. 51.
    P.A. Craven, M.A. Caines, F.R. DeRubertis, Sequential alterations in glomerular prostaglandin and thromboxane synthesis in diabetic rats: relationship to the hyperfiltration of early diabetes, Metabolism 36: 95–103 (1987).PubMedCrossRefGoogle Scholar
  52. 52.
    O.I. Moel, R.L. Safirstein, R.C. McEvoy, W. Hsueh, Effect of aspirin onexperimental diabetic nephropathy, J. Lab. Clin. Med. 110:300–307 (1987).PubMedGoogle Scholar
  53. 53.
    N. Bank, M.A.G. Lahorra, H.S. Aynedjian, D. Schlondorff, Vasoregulatory hormones and the hyperfiltration of diabetes, Am. J. Physiol. 254: F202-F209 (1988).PubMedGoogle Scholar
  54. 54.
    E. Esmatjes, M.R. Fernandez, I. Halpern, J. Camps, J. Gaye et al., Renal hemodynamic abnormalities in patients with short-term insulin-dependent diabetes mellitus: role of renal prostaglandins, J. Clin. Endocrinol. Metab. 60:1231–1236 (1985).PubMedCrossRefGoogle Scholar
  55. 55.
    S. Gambardella, G. Pugliese, A. Napoli, S. Morano, P. Pietravalle, F. Pugliese, G. Stirati, D. Andreani, Urinary excretion of prostaglandins and renal hemodynamics in Type I (insulin-dependent) diabetes at onset: effect of piroxicam, Diabetologia 29:53A (1986).CrossRefGoogle Scholar
  56. 56.
    G.C. Viberti, A. Benigni, E. Bognetti, G. Remuzzi, M.J. Wiseman, Glomerular hyperfiltration and urinary prostaglandins in insulin-dependent diabetes mellitus, In preparation.Google Scholar
  57. 57.
    J.S. Christiansen, B. Feldt-Rasmussen, H.H. Parving, Short-term inhibition of prostaglandin in synthesis has no effect on the elevated glomerular filtration rate of early insulin-dependent diabetes, Diabetic Med. 2:17–20 (1985).PubMedCrossRefGoogle Scholar
  58. 58.
    M.J. Wiseman, R. Mangili, H. Alberetto, H. Keen, G.C. Viberti, Glomerular response mechanisms to glycemic changes in insulin-dependent diabetics, Kidney Int. 31:1012–1018 (1987).PubMedCrossRefGoogle Scholar
  59. 59.
    B.L. Kasiske, M.P. O’Donneil, W.F. Keane, Glucose-induced increases in renal hemodynamic function: possible modulation by renal prostaglandins, Diabetes 34:360–364 (1985).PubMedCrossRefGoogle Scholar
  60. 60.
    D.A. Collier, D.M. Matthews, G. Beel, M.L. Watson, B.F. Clarke, Increased urinary excretion of 6-keto PGF and PGE2 in male insulin-dependent diabetics, Diabetic Med. 3:358A (1986).Google Scholar
  61. 61.
    E. Esmatjes, I. Levy, J. Gaya, F. Rivera, Renal excretion of prostaglandin E2 and plasma renin activity in Type I diabetes mellitus: relationship to normoglycemia achieved with artificial pancreas, Diabetes Care 10:428–431 (1987).PubMedCrossRefGoogle Scholar
  62. 62.
    G.C. Viberti and M.J. Wiseman, The kidney in diabetes: significance of early abnormalities, Clinics in Endocrin. Metab. 15:753–783 (1986).CrossRefGoogle Scholar
  63. 63.
    G.C. Viberti, R.J. Jarrett, M.J. Wiseman, Predicting diabetic nephropathy (letter), New Engl. J. Med. 311:1256–1257 (1984).PubMedCrossRefGoogle Scholar
  64. 64.
    S.L. Jones, M.J. Wiseman, G.C. Viberti, H. Keen, Glomerular hyperfiltration and albuminuria — A 5-year prospective study in Type I (insulin-dependent) diabetes mellitus, Diabetologia 30:536A (1987).CrossRefGoogle Scholar
  65. 65.
    M.J. Wiseman, A.J. Saunders, H. Keen, G.C. Viberti, Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes, N. Engl. J. Med. 312:617–621 (1985).PubMedCrossRefGoogle Scholar
  66. 66.
    J.J. Bending, G.C. Viberti, R.W. Bilous, H. Keen, For the Kroc Collaborative Study Group. Eight-month correction of hyperglycemia in insulin-dependent diabetes mellitus is associated with a significant and sustained reduction of urinary albumin excretion rates in patients with microalbuminuria, Diabetes 34 (Suppl.3):69–73 (1985).PubMedGoogle Scholar
  67. 67.
    K. Dahl-Jorgensen, O. Brinchmann-Hansen, K. Hanssen et al., Effect of near normoglycemia for two years on progression of early diabetic retinopathy, nephropathy and neuropathy: The Oslo Study, Br. Med. J. 293:1195–1199 (1986).CrossRefGoogle Scholar
  68. 68.
    C.K. Christensen and C.K. Mogensen, Antihypertensive treatment: longterm reversal of progression of albuminuria in incipient diabetic nephropathy. A longitudinal study of renal function, J. Diab. Compilc. 1:45–53 (1987).Google Scholar
  69. 69.
    M. Marre, H. Leblanc, L. Suarez, T.T. Guyenne, J. Menard, P. Pasa, Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria, Br. Med. J. 294:1448–1452 (1987).CrossRefGoogle Scholar
  70. 70.
    D.L. Cohen, R. Dodds, G.C. Viberti, Effects of protein restriction in insulin-dependent diabetics at risk of nephropathy, Br. Med. J. 294: 795–798 (1987).CrossRefGoogle Scholar
  71. 71.
    R. Zatz, T.W. Meyer, H. Rennke, B.M. Brenner, Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy, Proc. Natl. Acad. Sci. USA 82:5963–5967 (1985).PubMedCrossRefGoogle Scholar
  72. 72.
    M.J. Wiseman, R. Hunt, A. Goodwin, J.L. Gross, H. Keen, G.C. Viberti, Dietary composition and renal function in healthy subjects, Nephron 46:37–42 (1987).PubMedCrossRefGoogle Scholar
  73. 73.
    A. Beyer-Mears, The polyol pathway, sorbinil and renal dysfunction, Metabolism 35 (Suppl. 1):46–54 (1986).PubMedCrossRefGoogle Scholar
  74. 74.
    W.G. Oakley, D.A. Pyke, R.B. Tattersail, P.J. Watkin, Long-term diabetes. A clinical study of 92 patients after forty years, Q. J. Med. 43:145–156 (1974).PubMedGoogle Scholar
  75. 75.
    G.C. Viberti, H. Keen, M.J. Wiseman, Raised arterial pressure in parents of proteinuric insulin-dependent diabetics, Brit. Med. J. 295:575–577 (1987).CrossRefGoogle Scholar
  76. 76.
    R. Mangili, J.J. Bending, G.S. Scott, L.K. Li, A. Gupta, G.C. Viberti, Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy, N. Engl. J. Med. 318:146–149 (1988).PubMedCrossRefGoogle Scholar
  77. 77.
    A.S. Krolewski, M. Canessa, J.H. Warram, L.M.B. Laffel, R. Christlieb, W.C. Knowles, L.I. Rand, Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus, N. Engl. J. Med. 318:140–145 (1988).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • GianCarlo Viberti
    • 1
  • James D. Walker
    • 1
  1. 1.Unit for Metabolic MedicineUMDS (Guy’s Hospital Campus)LondonUK

Personalised recommendations